Skip to main content

Bank of New York Mellon Corp

Bank

Position in IMVT — Immunovant, Inc.

CIK 1390777 NEW YORK, NY

Position in IMVT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$5,371,025
+$303,196 QoQ
Shares Held
216,225
+8.5% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,725,512 across 270 Biotechnology names. IMVT ranks #82 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMVT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,371,025 216,225
2025-12-31 $5,067,829 199,364
2025-09-30 $3,255,511 201,955
2025-06-30 $3,034,608 189,663
2025-03-31 $3,450,657 201,911
2024-12-31 $5,029,817 203,061
2024-09-30 $5,787,498 202,999
2024-06-30 $6,608,948 250,339
2024-03-31 $7,185,062 222,379
2023-12-31 $10,314,685 244,830
2023-09-30 $7,379,094 192,214
2023-06-30 $3,463,276 182,566
2023-03-31 $2,622,337 169,074
2022-12-31 $2,973,302 167,510
2022-09-30 $835,179 149,674
2022-06-30 $551,588 141,433
2022-03-31 $808,862 146,799
2021-12-31 $1,242,778 145,866
2021-09-30 $1,220,710 140,473
2021-06-30 $1,298,714 122,868
2021-03-31 $2,389,157 148,950
2020-09-30 $5,434,953 154,446
2020-06-30 $1,828,781 75,104